DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /BenzimidazolesBenzimidazoles
  6. /Ethanesulfonamide, N-(1-((4,4-difluorocyclohexyl)methyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl)-CAS 881413-29-2
Chemical structure of CAS 881413-29-2

Ethanesulfonamide, N-(1-((4,4-difluorocyclohexyl)methyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl)-

In Stock•Starting at $241 for 1 mg
CAS No.881413-29-2
MDL No.N/A
MFC20H29F2N3O2S
MW413.50
InChI KeyZAGGGZCIFUQHOH-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$241In Stock
5 mgTo Be Confirmed$605In Stock
10 mgTo Be Confirmed$881In Stock
25 mgTo Be Confirmed$1384In Stock
50 mgTo Be Confirmed$1801In Stock
100 mgTo Be Confirmed$2517In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.881413-29-2
Product NameEthanesulfonamide, N-(1-((4,4-difluorocyclohexyl)methyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl)-
Heavy Atom Count28Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA4HBD1
TPSA63.990 ŲCharge0
Exact Mass413.19485Complexity951.72
pKa9.247XLogP4.921

Related Articles

Studies related to this compound and its mechanism of action

Benzo[d]thiazol-2(3H)-ones as new potent selective CB agonists with anti-inflammatory properties.

European journal of medicinal chemistry • Vol. 165 • 2019
PMID: 30583970DOI: 10.1016/j.ejmech.2018.12.008

Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal.

Scandinavian journal of pain • Vol. 4, Issue 1 • 2013
PMID: 29913883DOI: 10.1016/j.sjpain.2012.08.004

Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia.

Clinical and experimental pharmacology & physiology • Vol. 40, Issue 3 • 2013
PMID: 23324098DOI: 10.1111/1440-1681.12051

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact